Dear Sir, Please find Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended 30.09.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has submitted to BSE a quarterly compliance certificate from its Registrar and Share Transfer Agent, Alankit Assignments Limited, as required under SEBI (Depositories and Participants) Regulations, 2018. The certificate, dated October 6, 2025, covers the quarter ending September 30, 2025. It confirms that securities received from depository participants for dematerialization during the quarter were duly processed, certificates have been mutilated and cancelled, and the depository's name has been substituted as the registered owner in the company's register of members within the prescribed time limits. The letter is signed by the company's Managing Director, Bhawani Shankar Goyal (DIN: 03253804).
This is a routine regulatory compliance filing with no material impact on the company's financials, operations, or stock price. It simply confirms the proper processing of dematerialization requests during the quarter, indicating standard share transfer and depository operations are functioning normally.